Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (Q68101494)
Jump to navigation
Jump to search
scientific article published on 01 May 1992
Language | Label | Description | Also known as |
---|---|---|---|
English | Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group |
scientific article published on 01 May 1992 |
Statements
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (English)
K. Mattson
A. Kirkpatrick
D. Evrard
L. Tammilehto
F. J. van Breukelen
H. T. Planteydt